HINDUSTAN UNILEVER LTD. β Q2FY27 earnings call summary
Filed 04 November 2026 Β· Official transcript
- Multiple analyst queries on margin trajectory and volume outlook; management confident on volume-led growth and margin recovery
- Medium-term EBITDA margin guidance maintained at 22-24%
- Q2FY27 underlying sales growth (USG) 15%, underlying volume growth (UVG) 7%
- Rural demand growing sequentially, broad-based growth across categories and channels
- Pricing strategy passes absolute cost increases fully with calibrated price hikes
- EBITDA margin 22.6%, EBITDA Rs. 4,089 Cr (+8% y-y), PAT before exceptional items Rs. 2,795 Cr (+9% y-y)
- Home Care USG 22%, Beauty & Wellbeing USG 16%, Personal Care and Foods USG 9% each
- Strategy focuses on portfolio transformation, premiumisation, channel expansion, and AI-driven efficiencies
Open source transcript Β· View HINDUSTAN UNILEVER LTD. research
Sign in free to track HINDUSTAN UNILEVER LTD. and receive future summaries.